Just last week we sent the Super Serum to Dermscan in France for an eight week RCT or gold standard clinical trial. And at the end of that trial, we'll tell you exactly what happened. But the great thing about the gold standard trial is that we don't do it. Instead, the trial, which is a randomised, double-blind placebo trial is carried out by a dermatological institute, under the supervision of a dermatologist. It is the institute that does the trial and that publishes the report. Regardless of the result, we will have no input or control over what that trial report says. As far as we know, no other skin care company on Earth has ever told you in advance, that its serum is going to trial or has committed to telling you the results before the trial has even started. And why do we take that risk - because it is a pretty daunting risk - it's because one of our values is 'Truth.' We have no interest in deceiving any Snowberry customer about our products and what they will do. So, there may be some sleepless nights ahead, but on the other hand, we are very confident about the very high standard of skin science that Snowberry's Chief Scientist, Dr Travis Badenhorst and his team working at the University of Auckland, have accomplished. Hold onto your seat!